Similar articles

• [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].

  Rühle H. Rühle H. Z Arztl Fortbild (Jena). 1985;79(11):463-6. Z Arztl Fortbild (Jena). 1985. PMID: 3901541 Clinical Trial. German. No abstract available.
• [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].

  Schröder R. Schröder R. Dtsch Med Wochenschr. 1981 Apr 24;106(17):546-53. doi: 10.1055/s-2008-1070354. Dtsch Med Wochenschr. 1981. PMID: 6111439 Review. German. No abstract available.
• [Correction of thrombophilia].

  Caruzzo C, Marcolongo M, Arpino E, Di Summa M. Caruzzo C, et al. Minerva Cardioangiol. 1981 Jan-Feb;29(1-2):13-8. Minerva Cardioangiol. 1981. PMID: 6112717 Review. Italian. No abstract available.
• [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].

  Spitzer W, Durst OE, Lang E. Spitzer W, et al. Fortschr Med. 1983 Jan 13;101(1-2):22-30. Fortschr Med. 1983. PMID: 6826125 German.
• [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].

  Offerhaus L. Offerhaus L. Ned Tijdschr Geneeskd. 1983 Apr 16;127(16):673-9. Ned Tijdschr Geneeskd. 1983. PMID: 6134240 Clinical Trial. Dutch. No abstract available.